{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:47:04Z","timestamp":1790722024252,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006304","name":"Aalborg University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006304","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40266-025-01256-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:25Z","timestamp":1761058645000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends and Guideline Adherence in\u00a0Gabapentinoid\u00a0Use among Geriatric Outpatients: A Retrospective Cross-Sectional Study at a Falls Clinic"],"prefix":"10.1007","volume":"43","author":[{"given":"Hussein","family":"Alkafaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6784-0434","authenticated-orcid":false,"given":"Jesper","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Zintchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"1256_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a system. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"1256_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.5114\/aoms.2015.55270","volume":"5","author":"E Kozak-Szkopek","year":"2017","unstructured":"Kozak-Szkopek E, Broczek K, Slusarczyk P, et al. Prevalence of chronic pain in the elderly Polish population\u2014results of the PolSenior study. Arch Med Sci. 2017;5:1197\u2013206.","journal-title":"Arch Med Sci"},{"key":"1256_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","volume":"72","author":"SM Rikard","year":"2023","unstructured":"Rikard SM, Strahan AE, Schmit KM, et al. Chronic pain among adults - United States, 2019\u20132021. MMWR Morb Mortal Wkly Rep. 2023;72:379\u201385.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1256_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/jamainternmed.2022.5898","volume":"183","author":"A Han","year":"2023","unstructured":"Han A, Durant RW. Gabapentin will not cure the opioid crisis. JAMA Intern Med. 2023;183:94.","journal-title":"JAMA Intern Med"},{"key":"1256_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamainternmed.2022.5268","volume":"183","author":"ED Peet","year":"2023","unstructured":"Peet ED, Dana B, Sheng FY, et al. Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018. JAMA Intern Med. 2023;183:162\u20134.","journal-title":"JAMA Intern Med"},{"key":"1256_CR6","first-page":"2387","volume":"327","author":"BM Kuehn","year":"2022","unstructured":"Kuehn BM. Gabapentin increasingly implicated in overdose deaths. JAMA. 2022;327:2387.","journal-title":"JAMA"},{"key":"1256_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","volume":"178","author":"ME Johansen","year":"2018","unstructured":"Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med. 2018;178:292\u20134.","journal-title":"JAMA Intern Med"},{"key":"1256_CR8","unstructured":"Peter T. Deprescribing, a guide to deprescribing gabapentinoids. 2022."},{"key":"1256_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","volume":"179","author":"CW Goodman","year":"2019","unstructured":"Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019;179:695\u2013701.","journal-title":"JAMA Intern Med"},{"key":"1256_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/2049463720912496","volume":"14","author":"M Chincholkar","year":"2020","unstructured":"Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain. 2020;14:104\u201314.","journal-title":"Br J Pain"},{"key":"1256_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1528-1167.2010.02966.x","volume":"52","author":"G Zaccara","year":"2011","unstructured":"Zaccara G, Gangemi P, Perucca P, et al. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia. 2011;52:826\u201336.","journal-title":"Epilepsia"},{"key":"1256_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub3","author":"S Derry","year":"2019","unstructured":"Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD007076.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1256_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub4","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD007938.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"1256_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.maturitas.2014.06.013","volume":"79","author":"H Gaskell","year":"2014","unstructured":"Gaskell H, Derry S, Moore RA. Treating chronic non-cancer pain in older people\u2014more questions than answers? Maturitas. 2014;79:34\u201340.","journal-title":"Maturitas"},{"key":"1256_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/BCP.70060","author":"A Potteg\u00e5rd","year":"2025","unstructured":"Potteg\u00e5rd A, Rasmussen L, Olesen M, et al. Trends in gabapentinoid prescribing: a nationwide Danish drug utilization study. Br J Clin Pharmacol. 2025. https:\/\/doi.org\/10.1002\/BCP.70060.","journal-title":"Br J Clin Pharmacol"},{"key":"1256_CR16","unstructured":"Danmarks statistik. https:\/\/medstat.dk\/. Accessed 27 Nov 2024."},{"key":"1256_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1256_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4997\/JRCPE.2012.412","volume":"42","author":"P Moorhouse","year":"2012","unstructured":"Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb. 2012;42:333\u201340.","journal-title":"J R Coll Physicians Edinb"},{"key":"1256_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s41999-022-00686-6","volume":"13","author":"RS Kay","year":"2022","unstructured":"Kay RS, Hughes M, Williamson TR, et al. The clinical frailty scale can be used retrospectively to assess the frailty of patients with hip fracture: a validation study. Eur Geriatr Med. 2022;13:1101\u20137.","journal-title":"Eur Geriatr Med"},{"key":"1256_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"1256_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"1256_CR22","unstructured":"Sundhedsstyrelsen. Den Nationale Rekommandationsliste Farmakologisk Behandling Af Perifere Neuropatiske Smerter IRF. 2018."},{"key":"1256_CR23","unstructured":"Sundhedsstyrelsen. Nationale Kliniske Retningslinjer for Udredning Og Behandling Samt Rehabilitering Af Patienter Med Generaliserede Smerter i Bev\u00e6geapparatet. 2018."},{"key":"1256_CR24","unstructured":"Samplesize.net."},{"key":"1256_CR25","unstructured":"Douglas A. et al. Statistics with confidence: confidence intervals and statistical guidelines, 2nd Edition."},{"key":"1256_CR26","unstructured":"The R Project for Statistical Computing (version 4.4.1)."},{"key":"1256_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/add.14412","volume":"114","author":"R Cairns","year":"2019","unstructured":"Cairns R, Schaffer AL, Ryan N, et al. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Addiction. 2019;114:1026\u201334.","journal-title":"Addiction"},{"key":"1256_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6747","volume":"347","author":"D Spence","year":"2013","unstructured":"Spence D. Bad medicine: gabapentin and pregabalin. BMJ Br Med J. 2013;347:f6747.","journal-title":"BMJ Br Med J"},{"key":"1256_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.736688","author":"APA Dagnino","year":"2022","unstructured":"Dagnino APA, Campos MM. Chronic pain in the elderly: mechanisms and perspectives. Front Hum Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnhum.2022.736688.","journal-title":"Front Hum Neurosci"},{"key":"1256_CR30","unstructured":"Sundhedstyrelsen. Ny udleveringsstatus for visse opioider tr\u00e6der i kraft den 1. januar 2018. https:\/\/laegemiddelstyrelsen.dk\/da\/nyheder\/2017\/ny-udleveringsstatus-for-visse-opioider-traeder-i-kraft-den-1-januar-2018\/."},{"key":"1256_CR31","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1001\/jama.2017.4884","volume":"317","author":"K Kroenke","year":"2017","unstructured":"Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017;317:2365\u20136.","journal-title":"JAMA"},{"key":"1256_CR32","doi-asserted-by":"publisher","first-page":"E786","DOI":"10.1503\/cmaj.171333","volume":"190","author":"O Enke","year":"2018","unstructured":"Enke O, New HA, New CH, et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. Can Med Assoc J. 2018;190:E786.","journal-title":"Can Med Assoc J"},{"key":"1256_CR33","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000554","volume":"157","author":"JH Atkinson","year":"2016","unstructured":"Atkinson JH, Slater MA, Capparelli EV, et al. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016;157:1499\u2013507.","journal-title":"Pain"},{"key":"1256_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","volume":"376","author":"S Mathieson","year":"2017","unstructured":"Mathieson S, Maher CG, McLachlan AJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376:1111\u201320.","journal-title":"N Engl J Med"},{"key":"1256_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011790.pub2","author":"S Derry","year":"2016","unstructured":"Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD011790.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1256_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/jama.2017.21897","volume":"319","author":"JD Wallach","year":"2018","unstructured":"Wallach JD, Ross JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA. 2018;319:776\u20138.","journal-title":"JAMA"},{"key":"1256_CR37","doi-asserted-by":"publisher","first-page":"e2444488","DOI":"10.1001\/jamanetworkopen.2024.44488","volume":"7","author":"MTY Leung","year":"2024","unstructured":"Leung MTY, Turner JP, Marquina C, et al. Gabapentinoids and risk of hip fracture. JAMA Netw Open. 2024;7:e2444488\u2013e2444488.","journal-title":"JAMA Netw Open"},{"key":"1256_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40122-020-00189-x","volume":"9","author":"H McAnally","year":"2020","unstructured":"McAnally H, Bonnet U, Kaye AD. Gabapentinoid benefit and risk stratification: mechanisms over myth. Pain Ther. 2020;9:441\u201352.","journal-title":"Pain Ther"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01256-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01256-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01256-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:27:58Z","timestamp":1769696878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01256-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01256-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hussein Alkafaji, Jesper Schmidt, Johannes Riis, Dmitri Zintchouk, and Stig Andersen declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. This research was conducted as part of the authors\u2019 regular institutional duties and received no other financial support for the research, authorship, or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data were handled according to the General Data Protection Act, and the project was registered with the Danish Data Protection Agency (2024-013675). The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was approved by the Region of Northern Jutland in Denmark (F2024-085), which waived the need for informed consent for access to patient charts. The retrospective design of the study in combination with the age of the participants made it unfeasible to gain informed consent from participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation & publication)"}},{"value":"All authors took part in study conception and design. Jesper Schmidt and Hussein Alkafaji, as co-first authors, contributed equally to the work. Jesper Schmidt and Hussein Alkafaji collected data. Jesper Schmidt, Hussein Alkafaji, and Johannes Riis handled data-management and analysis. Jesper Schmidt and Hussein Alkafaji drafted the manuscript, while all other coauthors critically revised it. All authors read and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request. Data are located in controlled access data storage at Aalborg University Hospital.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}